J SAINI, MW RICH, AP LYSS - Annals of internal medicine, 1987 - Am Coll Physicians Doxorubicin is a potent anticancer agent effective in a wide range of
malignancies, but its use is limited by dose-dependent late cardiotoxicity.
Severe doxorubicin cardiotoxicity has been associated with a poor prognosis ... Cited by 45 - Related articles - All 3 versions
M Cohen, I Kronzon, A Lebowitz - Archives of Internal Medicine, 1982 - archinte.highwire.org \s=b\Doxorubicin hydrochloride is a chemotherapeutic agent highly effective
against a wide range of neoplasms. A prime limiting factor to the administration
of this drug is cardiotoxicity, which frequently develops when the ... Cited by 15 - Related articles - All 3 versions
RG Watts - Am J Hematol, 1991 - interscience.wiley.com Three cases of severe, progressive, and in two cases, fatal cardiomyopathy
secondary to anthracycline chemotherapy are reported. All of the patients were
receiving multiagent chemotherapy for extremity sarcomas consisting of ... Cited by 33 - Related articles - All 3 versions
CE Freter, TC Lee, ME Billingham, L Chak, … - The American journal of medicine, 1986 - Elsevier This report describes a patient treated for lymphoma who had development of
doxorubicin (Adriamycin) cardiotoxicity proved by endomyocardial biopsy seven
years after treatment. Doxorubicin cardiotoxicity is reviewed with emphasis ... Cited by 38 - Related articles - All 5 versions
- ►nih.gov [PDF] SA Mortensen, HS Olsen, U Baandrup - British Medical Journal, 1986 - heart.bmj.com SA MORTENSEN,* HS OLSEN,t U BAANDRUPt From the *Cardiovascular Laboratory
ofMedical Department B, Rigshospitalet, Copenhagen, Denmark; and the tUniversity
Institute ofPathology, Aarhus Municipal Hospital, Denmark Cited by 40 - Related articles - All 7 versions
RE Shaddy, SL Olsen, MR Bristow, DO Taylor, … - American Heart Journal, 1995 - Elsevier 4. SM Heilbrun, P Shah, MR Bristow, HA Valantine, R Ginsburg and MB Fowler,
Increased β-receptor density and improved hemodynamic response to catecholamine
stimulation during long-term metoprolol therapy in heart failure from ... Cited by 45 - Related articles - BL Direct - All 3 versions
ST Palmeri, RO Bonow, CE Myers, C Seipp, J … - The American journal of cardiology, 1986 - ncbi.nlm.nih.gov 1: Am J Cardiol. 1986 Sep 15;58(7):607-13. Prospective evaluation of doxorubicin
cardiotoxicity by rest and exercise radionuclide angiography. ... Cited by 73 - Related articles - All 2 versions
[CITATION] The diagnosis and treatment of drug-induced myocardial disease
RG Schwartz, BL Zaret - Cancer Treatment and the Heart, 1992 - Johns Hopkins Univ Pr Cited by 8 - Related articles
- ►nih.gov [PDF] W Rhoden, P Hasleton, N Brooks - British Medical Journal - heart.bmj.com The anthracyclines are effective and widely used antineoplastic agents. They are
used to treat many types of malignancy including acute lymphoblastic leukaemia.'
Their intro- duction has considerably improved survival, especially in ... Cited by 41 - Related articles - BL Direct - All 5 versions
MM Haq, SS Legha, J Choksi, GN Hortobagyi, … - CA A Cancer Journal for Clinicians - interscience.wiley.com The prognosis of doxorubicin-induced congestive heart failure (CHF) is reported
to be poor. To define the clinical course of doxorubicin-induced CHF, the
authors reviewed their experience with 43 patients with this diagnosis. The ... Cited by 56 - Related articles - All 3 versions
